✦ LIBER ✦

A randomized comparison of cyclophosphamide, DTIC with or without piperazinedione in metastatic malignant melanoma

✍ Scribed by Cary A. Presant; Alfred A. Bartolucci; Charles Balch; MICHAEL TRONER; MD AND THE SOUTHEASTERN CANCER STUDY GROUP

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 269 KB
Volume: 49
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19820401)49:7<1355::aid-cncr2820490708>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a randomized study comparing

Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma

✍ Mary E. Costanza; Larry Nathanson; William G. Costello; Janet Wolter; S. Fred Br 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 1 views

A phase III randomized trial of dacarbaz

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma

✍ Sanjiv S. Agarwala; William Ferri; William Gooding; John M. Kirkwood 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## BACKGROUND. Metastatic melanoma is a disease associated with a poor prognosis, and dacarbazine is still the reference agent. The authors conducted a randomized trial to test the benefit of adding tamoxifen to dacarbazine and carboplatin chemotherapy for previously untreated patients with metast

A randomized, double-blind comparison of

A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin

✍ Suzanne H. Stephens; V. Lee Silvey; Richard H. Wheeler 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 2 views

Thirty-seven patients with advanced incurable malignancies who were receiving their first course of cisplatin (2 90 mg/mz bolus), alone or in combination with other antineoplastic agents, were entered in this randomized, double-blind study to determine the antiemetic efficacy of the addition of high

Randomized trial of treatment with cispl

Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-α-2a in patients with metastatic melanoma : A Federation Nationale des Centres de Lutte Contre le Cancer Multicenter, parallel study

✍ Thierry Dorval; Sylvie Négrier; Christine Chevreau; Marie-Françoise Avril; Danie 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Background: The objective of the current study was to evaluate the response rate, survival, and toxicity of treatment with cisplatin and high dose intravenous continuous infusion interleukin-2 (il-2) with or without interferon-alpha-2a (ifn) in patients with metastatic melanoma. ## Methods: On